相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and Biological Features of Neuroendocrine Prostate Cancer
Yasutaka Yamada et al.
CURRENT ONCOLOGY REPORTS (2021)
Lactate Metabolism and Signaling in Tuberculosis and Cancer: A Comparative Review
Dilara Kiran et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches
Mark P. Labrecque et al.
ENDOCRINE-RELATED CANCER (2021)
Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
Dingxiao Zhang et al.
NATURE COMMUNICATIONS (2020)
Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
Takuma Uo et al.
FRONTIERS IN ONCOLOGY (2020)
Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer
John A. G. Moir et al.
PANCREAS (2020)
The Role of Lactate Metabolism in Prostate Cancer Progression and Metastases Revealed by Dual-Agent Hyperpolarized 13C MRSI
Robert Bok et al.
CANCERS (2019)
Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
Deepshikha Mishra et al.
CANCERS (2019)
Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
Zhenyu Jia et al.
FRONTIERS IN ONCOLOGY (2019)
Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Mark P. Labrecque et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer
Adam Sharp et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B
Marina Rosso et al.
CANCER & METABOLISM (2019)
Role and therapeutic potential of dietary ketone bodies in lymph vessel growth
Melissa Garcia-Caballero et al.
NATURE METABOLISM (2019)
HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancer
Daniel Hettel et al.
NATURE REVIEWS UROLOGY (2018)
Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer
Junchen Liu et al.
CANCER RESEARCH (2018)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Differential proteome expression analysis of androgen -dependent and -independent pathways in LNCaP prostate cancer cells
Seho Cha et al.
EXPERIMENTAL CELL RESEARCH (2017)
Targeting chaperonin containing TCP1 (CCT) as a molecular therapeutic for small cell lung cancer
Ana C. Carr et al.
ONCOTARGET (2017)
PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
Orielyz Flores et al.
THERANOSTICS (2017)
Lactate Dehydrogenase B Controls Lysosome Activity and Autophagy in Cancer
Lucie Brisson et al.
CANCER CELL (2016)
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2016)
Classical and Non- Classical Roles for Pre- Receptor Control of DHT Metabolism in Prostate Cancer Progression
Ailin Zhang et al.
HORMONES & CANCER (2016)
Targeting molecular resistance in castration-resistant prostate cancer
Thenappan Chandrasekar et al.
BMC MEDICINE (2015)
Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
Stefan J. Barfeld et al.
ONCOTARGET (2015)
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
M. Shipitsin et al.
BRITISH JOURNAL OF CANCER (2014)
Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer
L. Zhou et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer
Nicholas Mitsiades
CANCER RESEARCH (2013)
Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
Mark L. McCleland et al.
CLINICAL CANCER RESEARCH (2013)
Lactate Dehydrogenase B: A Metabolic Marker of Response to Neoadjuvant Chemotherapy in Breast Cancer
Jennifer B. Dennison et al.
CLINICAL CANCER RESEARCH (2013)
Quantitative Proteomics Reveals That Enzymes of the Ketogenic Pathway Are Associated with Prostate Cancer Progression
Punit Saraon et al.
MOLECULAR & CELLULAR PROTEOMICS (2013)
An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer
Mark L. McCleland et al.
CANCER RESEARCH (2012)
Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
Nicholas Mitsiades et al.
CANCER RESEARCH (2012)
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2012)
Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells
Monica Ciarlo et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Metabolic Enzyme IMPDH Is Also a Transcription Factor Regulated by Cellular State
Elena N. Kozhevnikova et al.
MOLECULAR CELL (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis
Zhao-dong Han et al.
MEDICAL ONCOLOGY (2012)
Roles of cAMP and cAMP-dependent protein kinase in the progression of prostate cancer: Cross-talk with the androgen receptor
Dennis Merkle et al.
CELLULAR SIGNALLING (2011)
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsy
Chuanyu Sun et al.
PROTEOME SCIENCE (2011)
Profiling Protein Markers Associated with Lymph Node Metastasis in Prostate Cancer by DIGE-based Proteomics Analysis
Jun Pang et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate Cancer
Amjad P. Khan et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Development of Androgen Receptor Antagonists with Promising Activity in Castration-Resistant Prostate Cancer
Howard C. Shen et al.
CANCER CELL (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Identification of the Transcription Factor Single-Minded Homologue 2 as a Potential Biomarker and Immunotherapy Target in Prostate Cancer
Mohamed S. Arredouani et al.
CLINICAL CANCER RESEARCH (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Prostate cancer serum biomarker discovery through proteomic analysis of alpha-2 macroglobulin protein complexes
Earle F. Burgess et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Integrative molecular concept modeling of prostate cancer progression
Scott A. Tomlins et al.
NATURE GENETICS (2007)
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
G. Wang et al.
ONCOGENE (2006)
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
A. Leiblich et al.
ONCOGENE (2006)
Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer
M Stanbrough et al.
CANCER RESEARCH (2006)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry
KL Meehan et al.
PROTEOMICS (2004)
Gleason grading and prognostic factors in carcinoma of the prostate
PA Humphrey
MODERN PATHOLOGY (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
J Lapointe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The androgen axis in recurrent prostate cancer
JL Mohler et al.
CLINICAL CANCER RESEARCH (2004)
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy
YP Yu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Androgen receptor signaling in androgen-refractory prostate cancer
ME Grossmann et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
分享论文
